Karl Bechter | Neuroscience | Interdisciplinary Innovation Prize

Prof Karl Bechter | Neuroscience | Interdisciplinary Innovation Prize 🏆


Professor at Ulm University , Germany🎓

Dr. Karl Bechter is a renowned psychiatrist and neurologist, known for his pioneering work on the role of Borna Disease Virus (BDV) in psychiatric and neurological disorders. He began his career at the University of Ulm, collaborating with leading virologists to investigate BDV’s impact on severe mental illnesses, such as depression and psychosis. Dr. Bechter introduced the Mild Encephalitis (ME) Hypothesis, suggesting that undetected neuroinflammation might underlie many psychiatric conditions. He has also developed innovative treatments, like cerebrospinal fluid filtration (CSFF), and contributed significantly to immunopsychiatry. His work has earned him prestigious awards, including the Kurt-Schneider Prize.

Professional Profile 

Education🎓

Dr. Karl Bechter began his medical career in neurology before transitioning to psychiatry at the University of Ulm. His early scientific work was influenced by collaborations with virologist Rudolf Rott at the University of Gießen, focusing on the role of Borna Disease Virus (BDV) in psychiatric disorders.

💼Work Experience

Dr. Bechter’s work primarily centers on exploring BDV infection’s impact on psychiatric conditions, such as severe depression and psychosis. Over several decades, he led extensive sero-epidemiological studies, involving more than 10,000 samples, and conducted groundbreaking research into mild neuroinflammation and autoimmune triggers in psychiatric patients. He also developed innovative treatments like cerebrospinal fluid filtration (CSFF) for therapy-resistant psychiatric patients.

🛠️Skills

Dr. Bechter is highly skilled in clinical psychiatry, neuroimmunology, neuroimaging, and cerebrospinal fluid (CSF) analysis. He also possesses deep expertise in experimental treatments for psychiatric disorders, notably pioneering immune-modulatory treatments like CSFF. His innovative work on mild neuroinflammation has helped shape modern neuropsychiatry.

🏆Awards and Honors

Dr. Bechter is highly skilled in clinical psychiatry, neuroimmunology, neuroimaging, and cerebrospinal fluid (CSF) analysis. He also possesses deep expertise in experimental treatments for psychiatric disorders, notably pioneering immune-modulatory treatments like CSFF. His innovative work on mild neuroinflammation has helped shape modern neuropsychiatry.

🌐 Memberships

Dr. Bechter has been an active participant in scientific communities, collaborating with leading virologists and psychiatrists from institutions like the University of Gießen, Freiburg, and Ulm. He has also contributed to international consensus projects, such as the recently established category of Autoimmune Psychosis (AP).

👩‍🏫 Teaching and Mentorship

As an accomplished academic, Dr. Bechter has taught numerous students at the University of Ulm. His unique expertise in neuroinflammation, autoimmune encephalitis, and psychiatric disorders has contributed to shaping new generations of psychiatrists and researchers.

Research Focus 🔬

 

Dr. Bechter’s research has focused on mild neuroinflammation, BDV, and its potential role in psychiatric disorders. He proposed the Mild Encephalitis (ME) Hypothesis, suggesting that a subgroup of psychiatric disorders could stem from undetected, low-grade encephalitis. His recent work explores cerebrospinal fluid (CSF) pathways, specifically the Peripheral CSF Outflow (PCOP) Hypothesis, which proposes new mechanisms for how CSF flows along peripheral nerves.

📖Publications : 

  • HSV-1 and Cellular miRNAs in CSF-Derived Exosomes as Diagnostically Relevant Biomarkers for Neuroinflammation
    🗓️ 2024-07-17
    📰 Cells
    DOI: 10.3390/cells13141208
    🔬 Topic: Neuroinflammation biomarkers in CSF-derived exosomes.
  • Old and New Biomarkers for Infection, Inflammation, and Autoimmunity in Treatment-Resistant Affective and Schizophrenic Spectrum Disorders
    🗓️ 2022-02-28
    📰 Pharmaceuticals
    DOI: 10.3390/ph15030299
    🔬 Topic: Biomarkers for infection and autoimmunity in resistant psychiatric disorders.
  • Immunological Causes of Obsessive-Compulsive Disorder: Is It Time for the Concept of an “Autoimmune OCD” Subtype?
    🗓️ 2022-01-10
    📰 Translational Psychiatry
    DOI: 10.1038/s41398-021-01700-4
    🧠 Topic: Autoimmune causes of OCD.
  • Alteration of NMDA Receptor Trafficking as a Cellular Hallmark of Psychosis
    🗓️ 2021-08-30
    📰 Translational Psychiatry
    DOI: 10.1038/s41398-021-01549-7
    🔬 Topic: NMDA receptor involvement in psychosis.
  • Upregulation of sICAM-1 and sVCAM-1 Levels in the Cerebrospinal Fluid of Patients with Schizophrenia Spectrum Disorders
    🗓️ 2021-06
    📰 Diagnostics
    DOI: 10.3390/diagnostics11071134
    🧠 Topic: Inflammatory markers in schizophrenia.
  • Diagnosing Organic Causes of Schizophrenia Spectrum Disorders: Findings from a One-Year Cohort of the Freiburg Diagnostic Protocol in Psychosis (FDPP)
    🗓️ 2020-09
    📰 Diagnostics
    DOI: 10.3390/diagnostics10090691
    🔬 Topic: Organic causes of schizophrenia.

Jingwen Wang | Vector-borne disease | Best Researcher Award

Prof Jingwen Wang | Vector-borne disease | Best Researcher Award 🏆


Professor at Fudan University, China🎓

Dr. Jingwen Wang is a leading expert in vector-borne diseases, currently serving as a professor at Fudan University, Shanghai. With a career dedicated to the study of mosquitoes and ticks, she has made significant contributions to the understanding of how microbiota influence vector competence and pathogen transmission. Dr. Wang’s work primarily focuses on developing innovative control strategies to reduce vector populations and limit the spread of diseases like malaria and babesiosis. Her research has global implications, as vector-borne diseases account for a substantial portion of infectious diseases worldwide.

 

Professional Profile 

Education🎓

Dr. Wang’s educational background is as impressive as her career. She earned her postgraduate degree from Yale University in 2006, where she also completed her postdoctoral fellowship. Dr. Wang holds a Ph.D. from Fudan University, Shanghai, obtained in 2006, and a Bachelor of Science degree from Shanghai University, completed in 2001. This solid foundation in both Chinese and international institutions has been pivotal in shaping her scientific expertise.

💼Work Experience

In her career, Dr. Wang has held numerous prestigious positions. Since 2019, she has been a professor at Fudan University, where she examines the metabolic and immune interactions between vectors and pathogens. Before that, she was an associate professor at the same university from 2014 to 2018, investigating gut microbiome influences on vector competence. Additionally, Dr. Wang spent time as an associate research scientist and postdoctoral fellow at Yale University, where she explored vector immune system development and pathogen-host interactions.

🛠️Skills

Dr. Wang has developed extensive skills in areas like RNAi, immunohistochemistry, and microbiome analysis. Her expertise also extends to studying host-microbiota metabolic interactions and applying cutting-edge molecular biology techniques to investigate vector-pathogen interactions.

🏆Awards and Honors

Her achievements have not gone unnoticed. In 2005, Dr. Wang received the Third Grade Student Award Scholarship at Fudan University, and in 2001, she was named an Outstanding Graduate by Shanghai University. These early accolades were followed by numerous research grants and collaborations with international organizations.

 

🌐 Memberships

She remains actively involved in professional communities through memberships in the Shanghai Society for Entomology and the Chinese Society of Insect Microbiome, among others. Dr. Wang also serves as a reviewer for several high-impact journals, including Trends in Parasitology and PLoS Pathogens.

👩‍🏫 Teaching and Mentorship

Beyond her research, Dr. Wang has been a dedicated teacher and mentor at Fudan University, guiding students and researchers in the fields of parasitology and vector biology. Her teaching philosophy is rooted in fostering curiosity and a deep understanding of global health challenges.

 Research Focus 🔬

Dr. Wang’s research is centered on the interaction between vectors, pathogens, and microbiota, with the aim of controlling vector populations and improving public health strategies. Her work explores how bacterial symbionts influence vector immune systems and how this knowledge can lead to novel interventions for reducing disease transmission.

📖Publications : 

  • 🦟 The Vector Competence of Asian Longhorned Ticks in Langat Virus Transmission (2024)
    Viruses
  • 🦋 Humidity Response in Drosophila Olfactory Sensory Neurons Requires the Mechanosensitive Channel TMEM63 (2022)
    Nature Communications
  • 🦠 Anopheline Mosquitoes Are Protected Against Parasite Infection by Tryptophan Catabolism in Gut Microbiota (2022)
    Nature Microbiology
  • 🧬 Antiviral RNA Interference in Disease Vector (Asian Longhorned) Ticks (2021)
    PLOS Pathogens
  • 🧪 Symbiont-Regulated Serotonin Biosynthesis Modulates Tick Feeding Activity (2021)
    Cell Host & Microbe
  • 🍬 Glucose-Mediated Proliferation of a Gut Commensal Bacterium Promotes Plasmodium Infection by Increasing Mosquito Midgut pH (2021)
    Cell Reports
  • 🧫 A Yeast-Based Drug Discovery Platform to Identify Plasmodium Falciparum Type II NADH Dehydrogenase Inhibitors (2021)
    Antimicrobial Agents and Chemotherapy
  • 🚫 Rapamycin Inhibits Pathogen Transmission in Mosquitoes by Promoting Immune Activation (2021)
    PLOS Pathogens
  • 🦟 The Microbiota of Three Anopheles Species in China (2021)
    Journal of the American Mosquito Control Association
  • 🍬 Glucose Transporter GLUT1 Influences Plasmodium Berghei Infection in Anopheles Stephensi (2020)
    Parasites & Vectors